Tabacon, Ruliet .

HRN: 21-85-49  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/23/2026
CEFUROXIME 1.5GM (VIAL)
01/23/2026
01/24/2026
IV
1.5g
PTOR
G5P4(4014) AUB Probably Endometrial Pathology
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: